Meet Alfa Cytology at the Cancer R&D 2024, Nov 18-20, 2024. We look forward to connecting with you and providing expert solutions for your cancer drug development projects.
Learn More
The presence of human T lymphotropic virus type 1 (HTLV-1) can lead to the development of adult T-cell leukemia. The detection and analysis of HTLV-1 sensitization play a crucial role in assessing the risk associated with HTLV-1 infection. Alfa Cytology provides services for the development of HTLV-1 assays, offering effective means to evaluate HTLV-1 infection and facilitate informed decision-making for subsequent steps. The accurate and reliable development of an HTLV-1 assay is of utmost importance in ensuring the effective diagnosis and monitoring of HTLV-1 infection.
At present, there are no targeted therapeutic interventions available for HTLV-1 infection or its associated disorders. The detection of HTLV-1 infection plays a pivotal role in diagnosing the underlying causes of adult T-cell leukemia or lymphoma, as well as HTLV-associated myelopathy. Furthermore, numerous countries' public health authorities routinely screen blood donors for HTLV-specific antibodies as a means to evaluate the risk of HTLV-1 transmission. Antibody and molecular testing serve as the primary approaches for HTLV-1 identification. Nonetheless, these methods have inherent limitations, underscoring the necessity for the development of assays with enhanced specificity.
Fig. 1. Flow chart of the screening and confirmation of HTLV-1 infection. (Bandeira, L.M. et al., 2021)
Alfa Cytology provides comprehensive HTLV-1 detection development services for the management and therapy of leukemia, including but not limited to the following.
We offer services for the development of HTLV-1 assay protocols designed specifically for use in animal models, enabling the analysis of HTLV-1 infection and the evaluation of residual risk. To address the potential uncertainty associated with confirmatory tests, we provide a diverse range of testing methods for you to choose from. By offering various experimental approaches, our aim is to ensure the accuracy and reliability of your research findings. Here are some HTLV-1 detection methods that we have the capability to develop:
| Technologies | Service Details |
| ELISA | We engineer antibodies of exquisite specificity, tailored to form an unwavering bond with the HTLV-1 antigens. Subsequently, the secondary antibodies, serving as the catalyst of detection, unleash their prowess in amplifying the signal, unfurling a realm of insight into the intricate landscape of HTLV-1 infection that resides within the very fabric of your samples. |
| Western Blotting | For immunoblotting analyses, we design monoclonal antibodies specific to HTLV-1-expressed proteins, such as gp21, gp46, and p24. A positive HTLV-1 antigen presence can be determined by using these antibodies, which enable accurate identification of positive HTLV-1 antigens in samples. |
| Particle Agglutination Assays | Through the process of agglutination of gel particles sensitized with HTLV-1 antigens, we can tailor gel particles to specifically detect HTLV-1, IgG, and IgM antibodies. The HTLV-1 titer was determined by mixing this gel pellet with the liquid to be tested and then observing the agglutination pattern. |
| Chemiluminescent Immunoassay | Using antibodies p19, p21, and p24 specific to HTLV-1, we develop a chemiluminescent immunoassay to diagnose HTLV-1 infection by detecting anti-HTLV-1 antibodies in serum. |
| Immunofluorescence Test | We employ immunofluorescence testing to visualize viral proteins expressed in fixed cells, enabling the analysis of HTLV-1 infection. This method, conducted under a fluorescence microscope, is well-suited for assessing cell samples and conducting cell-level analysis. |
| Radioimmunoprecipitation Assay | In our development process, we employ radiolabeled HTLV-1 antigens as a means to evaluate the existence of antibodies and proficiently scrutinize samples afflicted by HTLV-1. This innovative methodology facilitates the precise identification of antibody responses and contributes to the discernment of HTLV-1 infection. |
Within our repertoire of services, we present a plethora of promising candidates that hold the potential to serve as HTLV-1 biomarkers. Among these candidates, we offer an array of possibilities, including high HTLV-1 proviral load, select inflammatory cytokines, and the formidable HBZ, all poised to be explored as prospective biomarkers for HTLV-1. Through rigorous evaluation, we aim to ascertain the efficacy of these candidates as reliable indicators for the detection and characterization of HTLV-1.
Alfa Cytology is a renowned global provider of life sciences solutions, offering comprehensive development services for the detection of HTLV-1. Our services effectively support researchers and biotechnology developers in their endeavors. Feel free to contact us and discuss your specific research requirements.
Reference